期刊文献+

抗内皮细胞抗体在肾移植慢性排斥反应中的作用 被引量:4

The role of anti-endothelial cell antibodies in chronic rejection after renal transplantation
原文传递
导出
摘要 目的对临床发生慢性排斥反应的肾移植患者及移植术前透析患者的血清中的抗内皮细胞抗体(非HLA抗体)的含量进行定量检测,探讨在肾移植慢性排斥中非HLA抗体的作用。方法采用免疫荧光法对252份血清标本进行抗内皮细胞抗体的检测,包括移植前72例,移植后100例,正常对照组80例。结果移植前透析患者抗内皮细胞抗体的阳性率为38.89%(28/72),其中强阳性占13.89%(10/72),弱阳性占25.00%(18/72);移植后慢性排斥期患者抗内皮细胞抗体的阳性率为70.00%(70/100),其中强阳性占32.00%(32/100),弱阳性占38.00%(38/100);正常对照组抗内皮细胞抗体的阳性率为30.00%(24/80),其中强阳性为10.00%(8/80),弱阳性为20.00%(16/80)。移植前与正常对照组抗内皮细胞抗体含量无统计学意义(t=1.0105,P=0.1566),移植前后抗内皮细胞抗体含量差异有统计学意义(t=4.3311,P=0.0000),移植后与正常对照组抗内皮细胞抗体含量差异也具有统计学意义(t=5.5572,P=0.0000)。结论抗内皮细胞抗体作为非HLA抗体是肾移植慢性排斥反应的影响因素之一。 Objective To explore the role of non-HLA antibodies in chronic renal allograft rejection. Methods Immunofluorescence assay was performed to detect anti-endothelial cell antibodies in the serum sam- ples of 252 subjects including 72 patients receiving dialysis before renal transplantation, 100 patients after renal transplantation and 80 normal blood donors. Result Anti-endothelial cell antibodies were detected in 38.89% (28/72) patients before renal transplantation. The strong positive rate accounted for 13.89% (10/72), and the weak positive rate accounted for 25.00% ( 18/72 ). Anti-endothelial cell antibodies were detected in 70.00% (70/100) patients after transplantation, in which the strong positive rate accounted for 38.00% ( 38/ 100), while the weak positive rate accounted for 32.00% (32/100). Anti-endothelial cell antibodies were detected 30.00% (24/80) in normal blood donors, in which the strong positive rate was 10.00% (8/80) and the weak positive rate was 20.00% (16/80). The levels of anti-endothelial cell antibodies showed no difference between the pre-transplant group and normal control group ( t = 1. 0105,P = 0. 1566). The levels of anti- endo- thelial cell antibodies were significantly different between pre-transplant group and post-transplant group (t = 4. 3311 ,P = 0. 0000). The levels of anti-endothelial cell antibodies showed significant difference between post-transplant group and normal control group ( t = 5. 5572, P = 0. 0000 ). Conclusion Anti-endothelial cell antibodies were one of the important factors in chronic renal allograft rejection.
出处 《国际免疫学杂志》 CAS 2013年第1期54-56,共3页 International Journal of Immunology
基金 黑龙江省教育厅基金资助项目(11541197)
关键词 肾移植 抗内皮细胞抗体 非HLA抗体 慢性排斥反应 Renal transplantation Anti-endothelial cell antibody Non-HLA antibodies Chronic re- jection reaction
  • 相关文献

参考文献10

  • 1杨立(综述),卢一平(审校).非HLA抗原在实体器官移植中的作用[J].国际移植与血液净化杂志,2007,5(6):38-41. 被引量:1
  • 2Zou Y,Stastny P,Susal C,et al. Antibodies against MICA antigensand kidney Transplant rejection. N Engl J Med, 2007 ,357 ( 13 ):1293-1300.
  • 3Terasaki PI. Deduction of the fraction of immunologic and non-im-munologic failure in cadaver donor transplants. Clinical Trans-plants,2003,449452.
  • 4Mauiyyedi S,Crespo M,Collins AB,et al. Acute humoral rejectionin kidney transplantati- on: II Morphology, immunopathology andpathologic classification. J Am Soc Nephrol, 2002,13 (3 ) :779-787.
  • 5Regele H. Non-HLA antibodies in kidney allograft rejection: con-vincing concept in need of further evidence. Kidney Int,2011,79(6) :583-586.
  • 6Wang R,wang H,Chen J,et al. C4d deposition in allograft renalbiopsies is an independent risk fact for graft faiure. Nephrology(Carton) ,2009,14(5) :527-532.
  • 7Zou Y, Stastny P. The role of major histocompatibility complexclass chain- related gene A antibodies in organ transplantation.Curr Opin Organ Transplant,2009,14(4) :414-418.
  • 8孙启全,刘志红,陈劲松,唐政,季曙明,陈惠萍,曾彩虹,周虹,黎磊石.肾移植术后血清抗内皮细胞抗体阳性的急性体液性排斥[J].肾脏病与透析肾移植杂志,2005,14(5):439-440. 被引量:1
  • 9Sun Q, Cheng Z,Cheng D, et al. De novo development of circu-lating anti-endothelial cell antibodies rather than pre-existinganti-bodies is associated with post-transplant allograft rejection. KidneyInt,2011 ,79(6) :655-662.
  • 10Nakagawa Y,Saito K,Morioka T,et al. The clinical significanceof antibody to vascular endothelial cells after renal transplanta-tion. Clin Transplant ,2002,16 ( Suppl8) :51-57.

二级参考文献2

同被引文献55

  • 1李川江,于立新,徐健,付绍杰,邓文锋,杜传福,王亦斌.sCD30动态监测在移植肾急性排斥反应时的意义[J].广东医学,2008,29(2):245-246. 被引量:1
  • 2BolléeG, CochatP, DaudonM. Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria[J]. Can J Kidney Health Dis, 2015, 2:31. DOI:10.1186/s40697-015-0069-2.
  • 3HoPW, PangWF, SzetoCC.Remote ischemic pre-conditioning for the prevention of acute kidney injury[J/OL]. Nephrology (Carlton), 2015.[2015-10-10]http://onlinelibrary.wiley.com/doi/10.1111/nep.12614.[published online ahead of print September 15,2015]DOI:10.1111/nep.12614.
  • 4LiL, LiN, PangW, et al. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis[J]. PLoS One, 2014, 9:e94092. DOI:10.1371/journal.pone.0094092.
  • 5BasileDP, YoderMC. Circulating and tissue resident endothelial progenitor cells[J]. J Cell Physiol, 2014, 229:10-16. DOI:10.1002/jcp.24423.
  • 6RabbH. Paracrine and differentiation mechanisms underlying stem cell therapy for the damaged kidney[J]. Am J Physiol Renal Physiol, 2005, 289:F29-30. DOI:10.1152/ajprenal.00102.2005.
  • 7SongY, LiX, WangD, et al. Transcription factor Krüppel-like factor 2 plays a vital role in endothelial colony forming cells differentiation[J]. Cardiovasc Res, 2013, 99:514-524. DOI:10.1093/cvr/cvt113.
  • 8GeYZ. Wu R, Lu TZ, et al. Circulating endothelial progenitor cell:a promising biomarker in clinical oncology[J]. Med Oncol, 2015, 32:332. DOI:10.1007/s12032-014-0332-x.
  • 9KhalifehT, BaulierE, Le PapeS, et al. Strategies to optimize kidney recovery and preservation in transplantation:specific aspects in pediatric transplantation[J]. Pediatr Nephrol, 2015, 30:1243-1254. DOI:10.1007/s00467-014-2924-2.
  • 10SpectorAA, FangX, SnyderGD, et al. Epoxyeicosatrienoic acids (EETs):metabolism and biochemical function[J]. Prog Lipid Res, 2004, 43:55-90. DOI:10.1016/S0163-7827(03)00049-3.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部